Cell-penetrating peptides improve the gene transfer efficiency of virus-based nanoparticles while affecting their stability differently depending on CPP type.
Enhanced deliveryCPPs improved viral nanoparticle gene transfer efficiency in vitro
What the researchers found
CPPs enhance viral nanoparticle gene delivery efficiency, with different CPP types showing distinct effects on nanoparticle activity and stability.
Why it matters
Viral gene therapy vectors often have limited efficiency. CPPs could boost their performance, making gene therapy more effective at lower doses.
The numbers in context
3/4 CPPs enhanced; R8 destabilized; KH27K aggregated; LAH4 disassembled; FUSO no effect; HS-independent
How the study worked
In vitro gene transfer assays with four different CPPs conjugated to viral nanoparticles, stability assessments.
Who was studied
In vitro polyomavirus gene transfer assays
What this study cannot tell us
In vitro study. CPP-vector interactions may differ in vivo. Immunogenicity and toxicity not assessed.
How to read the evidence
In vitro study comparing multiple CPPs. Informative for optimization but needs in vivo validation.
When this study was published
Published in 2020.
The bigger picture
Combining CPPs with viral vectors could improve the next generation of gene therapies for genetic diseases and cancer.
Questions still open
- Which CPP-vector combination provides the best in vivo gene delivery?
- Do CPPs affect the immunogenicity of viral vectors?
- Can CPP enhancement reduce the viral dose needed for therapeutic effect?
Common questions
How do cell-penetrating peptides help gene therapy?
Why test different CPPs?
Read the original research
Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles.
International journal of pharmaceutics, 576, 119008
Citation
Váňová, Jana; Hejtmánková, Alžběta; Žáčková Suchanová, Jiřina; Sauerová, Pavla; Forstová, Jitka; Hubálek Kalbáčová, Marie; Španielová, Hana. (2020). Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles.. International journal of pharmaceutics, 576, 119008. https://doi.org/10.1016/j.ijpharm.2019.119008